Cholesterol Modification of Smoothened Is Required for Hedgehog Signaling

Xu Xiao,Jing-Jie Tang,Chao Peng,Yan Wang,Lin Fu,Zhi-Ping Qiu,Yue Xiong,Lian-Fang Yang,Hai-Wei Cui,Xiao-Long He,Lei Yin,Wei Qi,Catherine C L Wong,Yun Zhao,Bo-Liang Li,Wen-Wei Qiu,Bao-Liang Song

DOI: https://doi.org/10.1016/j.molcel.2017.02.015

2017-04-06

Abstract:Hedgehog (Hh) has been known as the only cholesterol-modified morphogen playing pivotal roles in development and tumorigenesis. A major unsolved question is how Hh signaling regulates the activity of Smoothened (SMO). Here, we performed an unbiased biochemical screen and identified that SMO was covalently modified by cholesterol on the Asp95 (D95) residue through an ester bond. This modification was inhibited by Patched-1 (Ptch1) but enhanced by Hh. The SMO(D95N) mutation, which could not be cholesterol modified, was refractory to Hh-stimulated ciliary localization and failed to activate downstream signaling. Furthermore, homozygous SmoD99N/D99N (the equivalent residue in mouse) knockin mice were embryonic lethal with severe cardiac defects, phenocopying the Smo-/- mice. Together, the results of our study suggest that Hh signaling transduces to SMO through modulating its cholesterylation and provides a therapeutic opportunity to treat Hh-pathway-related cancers by targeting SMO cholesterylation.